Prognostic Values of Immunohistochemical Expression of RAD51 and NR1D1 in Tissues of Triple-Negative Breast Cancer (TNBC), Aclinicopathological study.
mohamed, A., Hemeda, R., Eladl, M., Gertallah, L., Eltaher, A., Kalmoush, A., Elfeky, M. (2025). Prognostic Values of Immunohistochemical Expression of RAD51 and NR1D1 in Tissues of Triple-Negative Breast Cancer (TNBC), Aclinicopathological study.. EKB Journal Management System, (), -. doi: 10.21608/zumj.2025.420568.4158
Asmaa Hussein mohamed; Rehab Hemeda; mona Mahmoud Eladl; Loay M Gertallah; Ahmed K Eltaher; Abd-Elfattah Kalmoush; Mariem A. Elfeky. "Prognostic Values of Immunohistochemical Expression of RAD51 and NR1D1 in Tissues of Triple-Negative Breast Cancer (TNBC), Aclinicopathological study.". EKB Journal Management System, , , 2025, -. doi: 10.21608/zumj.2025.420568.4158
mohamed, A., Hemeda, R., Eladl, M., Gertallah, L., Eltaher, A., Kalmoush, A., Elfeky, M. (2025). 'Prognostic Values of Immunohistochemical Expression of RAD51 and NR1D1 in Tissues of Triple-Negative Breast Cancer (TNBC), Aclinicopathological study.', EKB Journal Management System, (), pp. -. doi: 10.21608/zumj.2025.420568.4158
mohamed, A., Hemeda, R., Eladl, M., Gertallah, L., Eltaher, A., Kalmoush, A., Elfeky, M. Prognostic Values of Immunohistochemical Expression of RAD51 and NR1D1 in Tissues of Triple-Negative Breast Cancer (TNBC), Aclinicopathological study.. EKB Journal Management System, 2025; (): -. doi: 10.21608/zumj.2025.420568.4158